MY-1701P
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MY-1701P, covering 2025-12-08 to 2025-12-08. Get the full timeline:
Most recent: Clinical Trial Update: Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration